Serum I-CTP, CEA and CYFRA levels in patients with and without distant metastasis
. | Distant metastasis (+) . | Distant metastasis (−) . | P-value . |
---|---|---|---|
I-CTP (ng/ml) | 5.7 ± 2.3 | 3.8 ± 1.3 | <0.0001 |
CEA (ng/ml) | 60.3 ± 163.4 | 4.5 ± 7.4 | 0.0002 |
CYFRA (ng/ml) | 2.9 ± 2.9 | 2.5 ± 4.5 | 0.6745 |
. | Distant metastasis (+) . | Distant metastasis (−) . | P-value . |
---|---|---|---|
I-CTP (ng/ml) | 5.7 ± 2.3 | 3.8 ± 1.3 | <0.0001 |
CEA (ng/ml) | 60.3 ± 163.4 | 4.5 ± 7.4 | 0.0002 |
CYFRA (ng/ml) | 2.9 ± 2.9 | 2.5 ± 4.5 | 0.6745 |
CEA: carcinoembryonic antigen; I-CPT: type I collagen; CYFRA: cytokeratin-19 fragment.
Serum I-CTP, CEA and CYFRA levels in patients with and without distant metastasis
. | Distant metastasis (+) . | Distant metastasis (−) . | P-value . |
---|---|---|---|
I-CTP (ng/ml) | 5.7 ± 2.3 | 3.8 ± 1.3 | <0.0001 |
CEA (ng/ml) | 60.3 ± 163.4 | 4.5 ± 7.4 | 0.0002 |
CYFRA (ng/ml) | 2.9 ± 2.9 | 2.5 ± 4.5 | 0.6745 |
. | Distant metastasis (+) . | Distant metastasis (−) . | P-value . |
---|---|---|---|
I-CTP (ng/ml) | 5.7 ± 2.3 | 3.8 ± 1.3 | <0.0001 |
CEA (ng/ml) | 60.3 ± 163.4 | 4.5 ± 7.4 | 0.0002 |
CYFRA (ng/ml) | 2.9 ± 2.9 | 2.5 ± 4.5 | 0.6745 |
CEA: carcinoembryonic antigen; I-CPT: type I collagen; CYFRA: cytokeratin-19 fragment.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.